Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1091668/full |
| _version_ | 1828122141336272896 |
|---|---|
| author | Angela I. Schriek Marlies M. van Haaren Meliawati Poniman Gillian Dekkers Arthur E. H. Bentlage Marloes Grobben Gestur Vidarsson Rogier W. Sanders Rogier W. Sanders Theo Verrips Theo Verrips Teunis B. H. Geijtenbeek Raimond Heukers Neeltje A. Kootstra Steven W. de Taeye Marit J. van Gils |
| author_facet | Angela I. Schriek Marlies M. van Haaren Meliawati Poniman Gillian Dekkers Arthur E. H. Bentlage Marloes Grobben Gestur Vidarsson Rogier W. Sanders Rogier W. Sanders Theo Verrips Theo Verrips Teunis B. H. Geijtenbeek Raimond Heukers Neeltje A. Kootstra Steven W. de Taeye Marit J. van Gils |
| author_sort | Angela I. Schriek |
| collection | DOAJ |
| first_indexed | 2024-04-11T14:30:19Z |
| format | Article |
| id | doaj.art-ca4f0b22e0c048fb9ae67a69af492c55 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-11T14:30:19Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-ca4f0b22e0c048fb9ae67a69af492c552022-12-22T04:18:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-11-011310.3389/fimmu.2022.10916681091668Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functionsAngela I. Schriek0Marlies M. van Haaren1Meliawati Poniman2Gillian Dekkers3Arthur E. H. Bentlage4Marloes Grobben5Gestur Vidarsson6Rogier W. Sanders7Rogier W. Sanders8Theo Verrips9Theo Verrips10Teunis B. H. Geijtenbeek11Raimond Heukers12Neeltje A. Kootstra13Steven W. de Taeye14Marit J. van Gils15Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsQVQ Holding BV, Utrecht, NetherlandsDepartment of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsDepartment of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United StatesDepartment of Biology, Faculty of Sciences, Utrecht University, Utrecht, NetherlandsVerLin BV, Utrecht, NetherlandsDepartment of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsQVQ Holding BV, Utrecht, NetherlandsDepartment of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, NetherlandsDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlandshttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1091668/fullHIV-1nanobodiesneutralizationFc fusionFc-mediated effector functions |
| spellingShingle | Angela I. Schriek Marlies M. van Haaren Meliawati Poniman Gillian Dekkers Arthur E. H. Bentlage Marloes Grobben Gestur Vidarsson Rogier W. Sanders Rogier W. Sanders Theo Verrips Theo Verrips Teunis B. H. Geijtenbeek Raimond Heukers Neeltje A. Kootstra Steven W. de Taeye Marit J. van Gils Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions Frontiers in Immunology HIV-1 nanobodies neutralization Fc fusion Fc-mediated effector functions |
| title | Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions |
| title_full | Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions |
| title_fullStr | Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions |
| title_full_unstemmed | Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions |
| title_short | Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions |
| title_sort | corrigendum anti hiv 1 nanobody igg1 constructs with improved neutralization potency and the ability to mediate fc effector functions |
| topic | HIV-1 nanobodies neutralization Fc fusion Fc-mediated effector functions |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1091668/full |
| work_keys_str_mv | AT angelaischriek corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT marliesmvanhaaren corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT meliawatiponiman corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT gilliandekkers corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT arthurehbentlage corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT marloesgrobben corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT gesturvidarsson corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT rogierwsanders corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT rogierwsanders corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT theoverrips corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT theoverrips corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT teunisbhgeijtenbeek corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT raimondheukers corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT neeltjeakootstra corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT stevenwdetaeye corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions AT maritjvangils corrigendumantihiv1nanobodyigg1constructswithimprovedneutralizationpotencyandtheabilitytomediatefceffectorfunctions |